搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
Medindia
2 天
Pomalidomide: A Game-Changer in Treating Hereditary Hemorrhagic Telangiectasia
Learn about how Pomalidomide, a cancer drug, shows promise in treating hereditary hemorrhagic telangiectasia (HHT), a rare ...
The New England Journal of Medicine
4 天
Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia
Hereditary hemorrhagic telangiectasia (HHT) is characterized by extensive telangiectasias and arteriovenous malformations. The primary clinical manifestation is epistaxis that results in iron ...
bjo.bmj
5 天
Progressive inner retinal neurodegeneration in non-proliferative macular telangiectasia type 2
Purpose Patients with non-proliferative macular telangiectasia type 2 (MacTel) have ganglion cell layer (GCL) and nerve fibre ...
Daily
2 天
Clinical Trial Finds Bone Marrow Cancer Drugs Effective in Managing Rare Blood Disorder
A clinical trial supported by the National Institutes of Health (NIH) was stopped early after researchers found sufficient ...
devdiscourse
2 天
Breakthrough Medication for Rare Bleeding Disorder Offers New Hope
A trial found the drug pomalidomide effectively treats hereditary hemorrhagic telangiectasia (HHT), reducing nosebleeds and ...
3 天
on MSN
Clinical trial demonstrates success in treating rare blood disorder
A clinical trial has demonstrated that the cancer drug pomalidomide is safe and effective in treating hereditary hemorrhagic ...
GEN
2 天
Rare Bleeding Disorder, HHT, Treated Successfully with Cancer Drug in Clinical Trial
An NIH-supported clinical trial of pomalidomide in treating hereditary hemorrhagic telangiectasia stopped early due to ...
Nature
4 天
Thalidomide-like drug staunches bleeding from genetic disease
Severe nosebleeds caused by hereditary hemorrhagic telangiectasia dwinded in people who took a drug used to treat cancer.
health.economictimes.indiatimes
1 天
Bone marrow cancer drug shows success in treatment of blood disorder, finds study
The New England Journal of Medicine published the trial results, which show that patients with HHT who were administered the ...
techexplorist
1 天
Bone marrow cancer drug shows promise in treating rare bleeding disorder
A clinical trial was stopped early after researchers found that a bone marrow cancer drug, is safe and effective for treating ...
technologynetworks
3 天
Cancer Drug Shows Promise for Hereditary Bleeding Disorder
Hereditary hemorrhagic telangiectasia (HHT), the world's second-most-common inherited bleeding disorder, affects ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈